Stay updated on Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.

Latest updates to the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not relate to the study, and the page revision number has been updated to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding status notice banner has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedResults data and post dates have been updated on the study record, including new 'Results First Posted' timestamps. A related publication reference and updated Study Record Dates reflect the results timeline.SummaryDifference0.4%

- Check71 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference2%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed, and there are no changes to pricing, stock, or time-slot availability.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.